3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione
![]() |
- ₹0
- Product name: 3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione
- CAS: 198474-05-4
- MF: C12H9FN2O2
- MW: 232.21
- EINECS:
- MDL Number:MFCD25121820
- Synonyms:2,5-Pyrrolidinedione, 3-(5-fluoro-1H-indol-3-yl)-;3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione;3-(5-fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione;PF-06840003;PF 06840003;PF-06840003;EOS200271;PF-06840003 (racemate);3-(5-Fluoro-1H-indol-3-yl)-2,5-pyrrolidinedione
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|
Properties
Melting point :190-195 °C
Boiling point :533.2±50.0 °C(Predicted)
Density :1.464±0.06 g/cm3(Predicted)
storage temp. :Inert atmosphere,Room Temperature
solubility :Soluble in DMSO (up to at least 25 mg/ml)
form :solid
pka :9.13±0.50(Predicted)
color :White
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Boiling point :533.2±50.0 °C(Predicted)
Density :1.464±0.06 g/cm3(Predicted)
storage temp. :Inert atmosphere,Room Temperature
solubility :Soluble in DMSO (up to at least 25 mg/ml)
form :solid
pka :9.13±0.50(Predicted)
color :White
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
PF-06840003 (198474-05-4) is a potent (IC50?= 150 and 410 nM via two methods) and selective inhibitor of Indoleamine-2,3-dioxygenase (IDO1).1?In mice with syngeneic tumor grafts, it reduced intratumoral kynurenine levels by over 80%, inhibited tumor growth as monotherapy, and increased the efficacy of anti-PD-L1 therapy.2?PF-06840003 treatment combined with GM-CSF-secreting allogenic pancreatic tumor cell vaccine (GVAX) resulted in increased antitumor efficacy in a murine model of pancreatic ductal adenocarcinoma.3More related product prices
NLG919 914471-09-3 IDO-IN-1 PF06869206 947303-87-9 PF-9366 PF-6274484 PF-562271 PF-06281355 PF-05212384 PF-3758309 6-chloro-5-(4-(1-hydroxycyclobutyl)phenyl)-1H-indole-3-carboxylicacid PF 573228 717906-29-1 1-METHYL-D-TRYPTOPHAN 8-Nitrotryptanthrin PF 05105679 1144035-53-9 Oclacitinib PF-06447475Related product price
- 947303-87-9
₹15209.13-61258.68 - PF-3758309
₹23250 - 6-chloro-5-(4-(1-hydroxycyclobutyl)phenyl)-1H-indole-3-carboxylicacid
₹10954.9-44057.75